Moreover, this opens therapeutic perspectives for the potential applications of CM-derived proteins/peptides especially in type-2 diabetes and insulin resistance situations where insulin's action needs to be corrected and improved. This evidence concerns the gene INS and type 2 diabetes mellitus.